Thomas Deckwerth

Dr. Thomas Deckwerth has 20 years of industrial experience in the research and development of therapeutics and medical devices. Prior to Pascal, Dr. Deckwerth was Vice President of Cancer Drug Development at Presage Biosciences where he led preclinical development and clinical drug product manufacturing. As Senior Director of Biological Chemistry at Ikaria, he led and managed therapeutics and diagnostics projects in the critical care space. As Head of Cellular Pharmacology at Idun Pharmaceuticals, he worked in collaborations with Novartis on caspase inhibitors for stroke and with Abbott Laboratories in the development of bcl2/bclxL antagonists for cancer. He received his Ph.D. in neuroscience from Washington University School of Medicine.